Scientists race to develop Ebola drugs as outbreak surges
SMRTR summary
An Ebola outbreak in the Democratic Republic of the Congo and Uganda has killed 88 people among 336 suspected cases, and there are currently no approved treatments or vaccines for this specific strain — Ebola Bundibugyo virus. Scientists are racing to launch WHO-sponsored clinical trials for two experimental treatments: the antiviral remdesivir and an antibody treatment called MBP134, which has shown strong results in animal studies.
SMRTR provides this summary for quick context. The original article belongs to Scientific American.
Read the original article